Enliven Therapeutics (ELVN) Q2 2022 Earnings

3AugExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-2.24
-1.64
-1.03
-0.43

Details

Expected EPS
-0.4282
Actual EPS
-1.76
Surprise EPS
-1.33
Surprise Percent
+311.02%

Description

Enliven Therapeutics (ELVN) has reported earnings of -1.76 per share for Q2 2022.

0 Comments

Share your thoughts